by In2Pharma | Mar 10, 2022 | News
The Netherlands As of February 1, data on financial relationships between suppliers and healthcare professionals can be submitted to the Transparency Register for Healthcare (“Transparantieregister Zorg” or TRZ) for the year 2021. Compared to previous years the...
by In2Pharma | Feb 25, 2022 | News
Belgium On 03.02.2022, the Federal Parliament approved a law that adjusts the financing of the Federal Agency for Medicines and Health Products (FAMHP). This has been published in the Belgian Official Journal and will come into force soon. The law introduces new taxes...
by In2Pharma | Feb 25, 2022 | News
Europe A regulation strengthening the role of the EMA in crisis preparedness and management for medicinal products and medical devices has been published in the Official Journal of the EU (Regulation (EU) 2022/123 “on a reinforced role for the European Medicines...
by In2Pharma | Feb 17, 2022 | News
Europe EFPIA, representing the research-based pharmaceutical industry in Europe, releases the results of the in-depth survey it has carried out among its members to capture the state of play of the implementation of the 2014 EU Public Procurement Directive that ought...
by In2Pharma | Feb 17, 2022 | News
Luxembourg APL, the Association Pharmaceutique Luxembourgeoise, is a Luxembourg-based association founded in 2011. The APL’s mission is to promote better healthcare by encouraging therapeutic innovation in the field of medicines for human use in Luxembourg. It...
